NGS-based methylation profiling differentiates TCF3-HLF and TCF3-PBX1 positive B-cell acute lymphoblastic leukemia
- PMID: 29334255
- DOI: 10.2217/epi-2017-0080
NGS-based methylation profiling differentiates TCF3-HLF and TCF3-PBX1 positive B-cell acute lymphoblastic leukemia
Abstract
Aim: To determine whether methylation differences between mostly fatal TCF3-HLF and curable TCF3-PBX1 pediatric acute lymphoblastic leukemia subtypes can be associated with differential gene expression and remission.
Materials & methods: Five (extremely rare) TCF3-HLF versus five (very similar) TCF3-PBX1 patients were sampled before and after remission and analyzed using reduced representation bisulfite sequencing and RNA-sequencing.
Results: We identified 7000 differentially methylated CpG sites between subtypes, of which 78% had lower methylation levels in TCF3-HLF. Gene expression was negatively correlated with CpG sites in 23 genes. KBTBD11 clearly differed in methylation and expression between subtypes and before and after remission in TCF3-HLF samples.
Conclusion: KBTBD11 hypomethylation may be a promising potential target for further experimental validation especially for the TCF3-HLF subtype.
Keywords: ALL; DNA methylation; NGS; RNA-Seq; RRBS; epigenetics; epigenomics; leukemia; next-generation sequencing; transcriptomics.
Similar articles
-
Characterization of TCF3 rearrangements in pediatric B-lymphoblastic leukemia/lymphoma by mate-pair sequencing (MPseq) identifies complex genomic rearrangements and a novel TCF3/TEF gene fusion.Blood Cancer J. 2019 Oct 1;9(10):81. doi: 10.1038/s41408-019-0239-z. Blood Cancer J. 2019. PMID: 31575852 Free PMC article.
-
Proteogenomic profiling uncovers differential therapeutic vulnerabilities between TCF3::PBX1 and TCF3::HLF translocated B-cell acute lymphoblastic leukemia.Haematologica. 2024 Jul 1;109(7):2290-2296. doi: 10.3324/haematol.2023.283928. Haematologica. 2024. PMID: 38426288 Free PMC article. No abstract available.
-
Comprehensive chromosomal aberrations in a case of a patient with TCF3-HLF-positive BCP-ALL.BMC Med Genomics. 2020 Apr 3;13(1):58. doi: 10.1186/s12920-020-0709-y. BMC Med Genomics. 2020. PMID: 32245383 Free PMC article.
-
Regulation of the miRNA expression by TEL/AML1, BCR/ABL, MLL/AF4 and TCF3/PBX1 oncoproteins in acute lymphoblastic leukemia (Review).Oncol Rep. 2016 Sep;36(3):1226-32. doi: 10.3892/or.2016.4948. Epub 2016 Jul 19. Oncol Rep. 2016. PMID: 27431573 Review.
-
Transcription factor abnormalities in B-ALL leukemogenesis and treatment.Trends Cancer. 2023 Oct;9(10):855-870. doi: 10.1016/j.trecan.2023.06.004. Epub 2023 Jul 3. Trends Cancer. 2023. PMID: 37407363 Review.
Cited by
-
HLF is a promising prognostic, immunological, and therapeutic biomarker in human tumors.Biochem Biophys Rep. 2024 May 1;38:101725. doi: 10.1016/j.bbrep.2024.101725. eCollection 2024 Jul. Biochem Biophys Rep. 2024. PMID: 38711550 Free PMC article.
-
Kbtbd11 contributes to adipocyte homeostasis through the activation of upstream stimulatory factor 1.Heliyon. 2019 Nov 14;5(11):e02777. doi: 10.1016/j.heliyon.2019.e02777. eCollection 2019 Nov. Heliyon. 2019. PMID: 31844712 Free PMC article.
-
SLC22A3 methylation-mediated gene silencing predicts adverse prognosis in acute myeloid leukemia.Clin Epigenetics. 2022 Dec 2;14(1):162. doi: 10.1186/s13148-022-01373-w. Clin Epigenetics. 2022. PMID: 36461046 Free PMC article.
-
Implementation of RNA sequencing and array CGH in the diagnostic workflow of the AIEOP-BFM ALL 2017 trial on acute lymphoblastic leukemia.Ann Hematol. 2020 Apr;99(4):809-818. doi: 10.1007/s00277-020-03953-3. Epub 2020 Feb 20. Ann Hematol. 2020. PMID: 32078009 Free PMC article.
-
Epigenetics of Muscle- and Brain-Specific Expression of KLHL Family Genes.Int J Mol Sci. 2020 Nov 9;21(21):8394. doi: 10.3390/ijms21218394. Int J Mol Sci. 2020. PMID: 33182325 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
